SEC Company Response from GUIDED THERAPEUTICS INC (GTHP) (CIK 0000924515) (GTHP) — Oct 13, 2020
GUIDED THERAPEUTICS INC (GTHP) (CIK 0000924515)
Date: Oct. 13, 2020 · CIK: 0000924515 · Accession: 0001121781-20-000073
AI Filing Summary & Sentiment
File numbers found in text: 333-248712
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Attn: Timothy Buchmiller Re: Guided Therapeutics, Inc. Registration Statement on Form S-1 File No. 333-248712
Dear Mr. Buchmiller:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Guided Therapeutics, Inc. (the “Company”) hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:00 p.m. on Thursday, October 15, 2020, or as soon as thereafter practicable.
Please note that we acknowledge the following:
•
should the Securities and Exchange Commission (the “Commission”) or the staff (the “Staff”), acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
•
the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
•
the Company may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very
truly yours,
/s/
Gene S. Cartwright
Show Raw Text
CORRESP
1
filename1.htm
Guided
Therapeutics, Inc.
5835
Peachtree Corners East, Suite B
Norcross,
Georgia 30092
October
13, 2020
VIA
EDGAR
United
States Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
DC 20549
Attn:
Timothy Buchmiller
Re:
Guided
Therapeutics, Inc.
Registration
Statement on Form S-1
File
No. 333-248712
Dear
Mr. Buchmiller:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended, Guided Therapeutics, Inc. (the “Company”) hereby
requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:00
p.m. on Thursday, October 15, 2020, or as soon as thereafter practicable.
Please
note that we acknowledge the following:
•
should the Securities
and Exchange Commission (the “Commission”) or the staff (the “Staff”), acting pursuant
to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect
to the filing;
•
the action of the
Commission or the Staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company
from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
•
the Company may
not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission
or any person under the federal securities laws of the United States.
Very
truly yours,
/s/
Gene S. Cartwright
Gene
S. Cartwright
President,
Chief Executive Officer and Acting Chief Financial Officer